Deciding on the most instructive cancer-related genes from outsized gene expression database is a significant and compelling bioinformatics research topic. Prostate Cancer (PC) is globally prevalent type of cancer among men. Bio-markers approach as obligatory tools for therapeutic and evaluation since the impulsiveness of disease performance, the cost constraint, symptomatic of cure, associated miserable life style, which is required for efficient early detection technique. Fast-throughput equipment platforms in proteomics and genomics, increased the growth of bio-markers. In addition, latest developments on some agents in PC, as well as immune-therapy inspired to seek for predictors of reply and resistance and they have enhanced the though...
Genomics is the science of how genes influence human health and disease states. It differs from trad...
Worldwide, prostate cancer (PC) is the second-most-frequently diagnosed male cancer and the fifth-mo...
The main diagnostic biomarker in current use is prostate-specific antigen (PSA) and it is one of the...
[[abstract]]Prostate cancer (PCa) is the second-leading cause of cancer death among men in the world...
Prostate cancer is the most prevalent non-skin cancer in men and is the leading cause of cancer-rela...
Due to its significant applicability for early detection, risk prediction and follow-up evaluation, ...
Due to its significant applicability for early detection, risk prediction and follow-up evaluation, ...
Item does not contain fulltextSerum PSA testing has been used for over 20 years as an aid in the dia...
African American men in America are 65 % more likely to develop prostate cancer and are two to three...
There is clinically relevant molecular heterogeneity in prostate cancer (PCa), but this biological d...
Prostate cancer is one of the most commonly diagnosed malignancy and the fifth leading cause of canc...
CONTEXT: Although the widespread use of prostate-specific antigen (PSA) has led to an early detectio...
DNA microarray technology provides a means to examine large numbers of molecular changes related to ...
Despite advances in molecular medicine, genomics, proteomics and translational research, prostate ca...
Introduction: Prostate cancer (PCa) is one of the most common cancers worldwide and a leading cause ...
Genomics is the science of how genes influence human health and disease states. It differs from trad...
Worldwide, prostate cancer (PC) is the second-most-frequently diagnosed male cancer and the fifth-mo...
The main diagnostic biomarker in current use is prostate-specific antigen (PSA) and it is one of the...
[[abstract]]Prostate cancer (PCa) is the second-leading cause of cancer death among men in the world...
Prostate cancer is the most prevalent non-skin cancer in men and is the leading cause of cancer-rela...
Due to its significant applicability for early detection, risk prediction and follow-up evaluation, ...
Due to its significant applicability for early detection, risk prediction and follow-up evaluation, ...
Item does not contain fulltextSerum PSA testing has been used for over 20 years as an aid in the dia...
African American men in America are 65 % more likely to develop prostate cancer and are two to three...
There is clinically relevant molecular heterogeneity in prostate cancer (PCa), but this biological d...
Prostate cancer is one of the most commonly diagnosed malignancy and the fifth leading cause of canc...
CONTEXT: Although the widespread use of prostate-specific antigen (PSA) has led to an early detectio...
DNA microarray technology provides a means to examine large numbers of molecular changes related to ...
Despite advances in molecular medicine, genomics, proteomics and translational research, prostate ca...
Introduction: Prostate cancer (PCa) is one of the most common cancers worldwide and a leading cause ...
Genomics is the science of how genes influence human health and disease states. It differs from trad...
Worldwide, prostate cancer (PC) is the second-most-frequently diagnosed male cancer and the fifth-mo...
The main diagnostic biomarker in current use is prostate-specific antigen (PSA) and it is one of the...